Stay updated on SRP-5051 Safety in DMD Clinical Trial

Sign up to get notified when there's something new on the SRP-5051 Safety in DMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SRP-5051 Safety in DMD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to evaluating the safety, tolerability, and pharmacokinetics of SRP-5051 in patients with Duchenne Muscular Dystrophy amenable to exon 51 skipping treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:25:15.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for individuals with a genetic diagnosis of DMD and an out-of-frame deletion mutation of the DMD gene amenable to exon 51 skipping treatment. It also includes specific inclusion and exclusion criteria related to health conditions and prior treatments.
    Difference
    25%
    Check dated 2024-05-22T20:56:19.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:33:09.000Z thumbnail image

Stay in the know with updates to SRP-5051 Safety in DMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SRP-5051 Safety in DMD Clinical Trial page.